Titre:
  • Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
Auteur:Kluin-Nelemans, H C; Zagonel, V; Anastasopoulou, A; Bron, Dominique; Roozendaal, K J; Noordijk, E M; Musson, H; Teodorovic, Ivana; Maes, Björn; Carbone, A; Carde, Patrice; Thomas, José
Informations sur la publication:Journal of the National Cancer Institute, 93, 1, page (22-30)
Statut de publication:Publié, 2001-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Bleomycin -- administration & dosage
Cause of Death
Cyclophosphamide -- administration & dosage
Doxorubicin -- administration & dosage
Drug Administration Schedule
Europe
Female
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Non-Hodgkin -- drug therapy
Lymphoma, Non-Hodgkin -- radiotherapy
Lymphoma, Non-Hodgkin -- therapy
Male
Middle Aged
Prednisone -- administration & dosage
Prospective Studies
Radiotherapy, Adjuvant
Survival Analysis
Teniposide -- administration & dosage
Transplantation, Autologous
Treatment Outcome
Vincristine -- administration & dosage
Note générale:Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, U.S. Gov't, P.H.S.
Langue:Anglais
Identificateurs:urn:issn:0027-8874
info:pmid/11136838